Ignite Creation Date:
2025-12-24 @ 6:41 PM
Ignite Modification Date:
2026-01-05 @ 6:26 PM
Study NCT ID:
NCT00168857
Status:
COMPLETED
Last Update Posted:
2023-12-08
First Post:
2005-09-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Prospective, Randomised, Double-blind, Double-dummy, Forced-titration, Multicentre, Parallel Group, One Year Treatment Trial to Compare Telmisartan (MICARDIS) 80 mg Versus Losartan (COZAAR) 100 mg, in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy (AMADEO Study)
Sponsor:
Organization:
Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D006973', 'term': 'Hypertension'}, {'id': 'D003928', 'term': 'Diabetic Nephropathies'}], 'ancestors': [{'id': 'D014652', 'term': 'Vascular Diseases'}, {'id': 'D002318', 'term': 'Cardiovascular Diseases'}, {'id': 'D007674', 'term': 'Kidney Diseases'}, {'id': 'D014570', 'term': 'Urologic Diseases'}, {'id': 'D052776', 'term': 'Female Urogenital Diseases'}, {'id': 'D005261', 'term': 'Female Urogenital Diseases and Pregnancy Complications'}, {'id': 'D000091642', 'term': 'Urogenital Diseases'}, {'id': 'D052801', 'term': 'Male Urogenital Diseases'}, {'id': 'D048909', 'term': 'Diabetes Complications'}, {'id': 'D003920', 'term': 'Diabetes Mellitus'}, {'id': 'D004700', 'term': 'Endocrine System Diseases'}]}, 'interventionBrowseModule': {'meshes': [{'id': 'D000077333', 'term': 'Telmisartan'}, {'id': 'D019808', 'term': 'Losartan'}], 'ancestors': [{'id': 'D001713', 'term': 'Biphenyl Compounds'}, {'id': 'D001555', 'term': 'Benzene Derivatives'}, {'id': 'D006841', 'term': 'Hydrocarbons, Aromatic'}, {'id': 'D006844', 'term': 'Hydrocarbons, Cyclic'}, {'id': 'D006838', 'term': 'Hydrocarbons'}, {'id': 'D009930', 'term': 'Organic Chemicals'}, {'id': 'D001562', 'term': 'Benzimidazoles'}, {'id': 'D006574', 'term': 'Heterocyclic Compounds, 2-Ring'}, {'id': 'D000072471', 'term': 'Heterocyclic Compounds, Fused-Ring'}, {'id': 'D006571', 'term': 'Heterocyclic Compounds'}, {'id': 'D007093', 'term': 'Imidazoles'}, {'id': 'D001393', 'term': 'Azoles'}, {'id': 'D006573', 'term': 'Heterocyclic Compounds, 1-Ring'}, {'id': 'D013777', 'term': 'Tetrazoles'}]}}, 'protocolSection': {'designModule': {'phases': ['PHASE4'], 'studyType': 'INTERVENTIONAL', 'designInfo': {'allocation': 'RANDOMIZED', 'maskingInfo': {'masking': 'DOUBLE'}, 'primaryPurpose': 'TREATMENT', 'interventionModel': 'PARALLEL'}, 'enrollmentInfo': {'type': 'ACTUAL', 'count': 860}}, 'statusModule': {'overallStatus': 'COMPLETED', 'startDateStruct': {'date': '2003-07-09', 'type': 'ACTUAL'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2023-11', 'lastUpdateSubmitDate': '2023-12-01', 'studyFirstSubmitDate': '2005-09-09', 'studyFirstSubmitQcDate': '2005-09-14', 'lastUpdatePostDateStruct': {'date': '2023-12-08', 'type': 'ACTUAL'}, 'studyFirstPostDateStruct': {'date': '2005-09-15', 'type': 'ESTIMATED'}, 'primaryCompletionDateStruct': {'date': '2006-06-01', 'type': 'ACTUAL'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'Change from baseline after one year of treatment in proteinuria (ratio of protein to creatinine as measure in spot urine sample).', 'timeFrame': 'Up to 1 year'}], 'secondaryOutcomes': [{'measure': 'Change from baseline after one year of treatment in the following: glomerular filtration rate; serum creatinine; macroalbuminuria; sodium excretion; high sensitive C-reactive protein; serum aldosterone; and other renal and cardiovascular measures.', 'timeFrame': 'Up to 1 year'}]}, 'conditionsModule': {'conditions': ['Hypertension', 'Diabetic Nephropathies']}, 'referencesModule': {'references': [{'pmid': '38682786', 'type': 'DERIVED', 'citation': 'Natale P, Palmer SC, Navaneethan SD, Craig JC, Strippoli GF. Angiotensin-converting-enzyme inhibitors and angiotensin receptor blockers for preventing the progression of diabetic kidney disease. Cochrane Database Syst Rev. 2024 Apr 29;4(4):CD006257. doi: 10.1002/14651858.CD006257.pub2.'}, {'pmid': '18496508', 'type': 'DERIVED', 'citation': 'Bakris G, Burgess E, Weir M, Davidai G, Koval S; AMADEO Study Investigators. Telmisartan is more effective than losartan in reducing proteinuria in patients with diabetic nephropathy. Kidney Int. 2008 Aug;74(3):364-9. doi: 10.1038/ki.2008.204. Epub 2008 May 21.'}]}, 'descriptionModule': {'briefSummary': 'A number of blood pressure lowering drugs in the class known as angiotensin receptor blockers (ARB) have been shown to slow the decline in kidney function of patients with type 2 diabetes, high blood pressure, and kidney disease. Losartan (COZAAR), is one such drug. The purpose of this research study is to determine if after one year of treatment telmisartan (MICARDIS, GLIOSARTAN, KINZAL, KINZALMONO, PREDXAL, PRITOR, SAMERTAN, TELMISARTAN) 80 mg, another blood pressure lowering drug from the ARB class, is as effective as losartan (COZAAR) 100 mg in reducing the level of urinary protein (indicative of improved kidney function).'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT', 'OLDER_ADULT'], 'maximumAge': '80 Years', 'minimumAge': '21 Years', 'healthyVolunteers': False, 'eligibilityCriteria': "Inclusion criteria:\n\n* Ability to provide written informed consent in accordance with Good Clinical Practice (GCP) and local legislation\n* Age 21-80 years\n* Clinical history of type 2 diabetes mellitus, as defined by either:\n\n * Hyperglycaemia not requiring insulin (diet, oral hypoglycaemic agents and metformin if patients serum creatinine levels were within normal limits.)\n * Hyperglycaemia requiring insulin with: no history of diabetic ketoacidosis AND with either the period between diagnosis and insulin usage \\>1 year or elevated fasting or stimulated C-peptide level\n* Glycosylated haemoglobin A1 (HbA1c) ≤10%\n* Diabetic nephropathy, as defined by:\n\n * serum creatinine at Screening (Visit 1) ≤265 μmol/L (3.0 mg/dL) in women and ≤283 μmol/L (3.2 mg/dL) in men\n * urinary protein/creatinine ratio ≥700 mg/g (measured in spot urine) during the run-in phase (Visit 2 or Visit 5 retest)\n* Hypertension at screening, as defined by either:\n\n * Mean systolic blood pressure (SBP) \\>130 mmHg and/or mean diastolic blood pressure (DBP) \\>80 mmHg in untreated patients\n * Patients currently receiving antihypertensive medication (i.e. medications specifically prescribed to treat hypertension)\n* Ability to stop current antihypertensive therapy with Angiotensin Converting Enzyme Inhibitor (ACE-Is), Angiotensin Receptor Blockers (ARBs) and direct vasodilators, and to stop chronic immunosuppressive therapy and current therapy with metformin without risk to the patient (Investigator's discretion).\n* All female patients had to have negative results from the urine pregnancy test (UPT) at Visits 1 and 6 in order to be able to continue in the study.\n\nExclusion criteria:\n\n* Pre-menopausal women (last menstruation ≤1 year prior to signing informed consent) who:\n\n * were not surgically sterile or\n * were nursing or pregnant or\n * were of child-bearing potential and were not practicing acceptable methods of birth control, or did not plan to continue practicing an acceptable method throughout the study (Note: Acceptable methods of birth control included transdermal patch, intra-uterine device, oral, implantable or injectable contraceptives) AND did not agree to periodic urine pregnancy testing (UPT) during participation in the study. No exceptions were made.\n* Type 1 diabetes mellitus\n* Increase of serum creatinine \\>35% between Visit 1 (Screening) and Visit 5. If creatinine was increased \\>35% at Visit 5, the measurement was to be repeated within five calendar days and if the increase was confirmed, the patient had to be excluded from the trial for safety reasons.\n* Non-diabetic renal disease\n* Congestive heart failure (New York Heart Association functional class III or IV)\n* Unstable angina, myocardial infarction, coronary artery bypass graft surgery, or percutaneous coronary intervention within the last three months prior to signing the informed consent form\n* Stroke or transient ischaemic attack within the last six months prior to signing the informed consent form\n* Hypertrophic obstructive cardiomyopathy, hemodynamically relevant stenosis of the aortic or mitral valve\n* Further exclusion criteria apply"}, 'identificationModule': {'nctId': 'NCT00168857', 'briefTitle': 'A Prospective, Randomised, Double-blind, Double-dummy, Forced-titration, Multicentre, Parallel Group, One Year Treatment Trial to Compare Telmisartan (MICARDIS) 80 mg Versus Losartan (COZAAR) 100 mg, in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy (AMADEO Study)', 'organization': {'class': 'INDUSTRY', 'fullName': 'Boehringer Ingelheim'}, 'officialTitle': 'A Prospective, Randomised, Double-blind, Double-dummy, Forced-titration, Multicentre, Parallel Group, One Year Treatment Trial to Compare MICARDIS® (Telmisartan) 80 mg Versus COZAAR® (Losartan) 100 mg, in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy (AMADEO Study)', 'orgStudyIdInfo': {'id': '502.397'}}, 'armsInterventionsModule': {'interventions': [{'name': 'telmisartan', 'type': 'DRUG'}, {'name': 'losartan', 'type': 'DRUG'}]}, 'contactsLocationsModule': {'locations': [{'city': 'Montgomery', 'state': 'Alabama', 'country': 'United States', 'facility': 'Boehringer Ingelheim Investigational Site', 'geoPoint': {'lat': 32.36681, 'lon': -86.29997}}, {'city': 'Little Rock', 'state': 'Arkansas', 'country': 'United States', 'facility': 'Boehringer Ingelheim Investigational Site', 'geoPoint': {'lat': 34.74648, 'lon': -92.28959}}, {'city': 'Lancaster', 'state': 'California', 'country': 'United States', 'facility': 'Boehringer Ingelheim Investigational Site', 'geoPoint': {'lat': 34.69804, 'lon': -118.13674}}, {'city': 'Los Angeles', 'state': 'California', 'country': 'United States', 'facility': 'Boehringer Ingelheim Investigational Site', 'geoPoint': {'lat': 34.05223, 'lon': -118.24368}}, {'city': 'Los Angeles', 'state': 'California', 'country': 'United States', 'facility': 'VA of Greater Los Angeles', 'geoPoint': {'lat': 34.05223, 'lon': -118.24368}}, {'city': 'Orange', 'state': 'California', 'country': 'United States', 'facility': 'UCI Medical Center', 'geoPoint': {'lat': 33.78779, 'lon': -117.85311}}, {'city': 'San Diego', 'state': 'California', 'country': 'United States', 'facility': 'VA San Diego Healthcare System', 'geoPoint': {'lat': 32.71571, 'lon': -117.16472}}, {'city': 'Santa Ana', 'state': 'California', 'country': 'United States', 'facility': 'Boehringer Ingelheim Investigational Site', 'geoPoint': {'lat': 33.74557, 'lon': -117.86783}}, {'city': 'Sylmar', 'state': 'California', 'country': 'United States', 'facility': 'UCLA Medical Center', 'geoPoint': {'lat': 34.30778, 'lon': -118.44925}}, {'city': 'Torrance', 'state': 'California', 'country': 'United States', 'facility': 'Torrance Clinical Research', 'geoPoint': {'lat': 33.83585, 'lon': -118.34063}}, {'city': 'Denver', 'state': 'Colorado', 'country': 'United States', 'facility': 'University of Colorado Health Sciences Center', 'geoPoint': {'lat': 39.73915, 'lon': -104.9847}}, {'city': 'Wheat Ridge', 'state': 'Colorado', 'country': 'United States', 'facility': 'Boehringer Ingelheim Investigational Site', 'geoPoint': {'lat': 39.7661, 'lon': -105.07721}}, {'city': 'Washington D.C.', 'state': 'District of Columbia', 'country': 'United States', 'facility': 'George Washington University', 'geoPoint': {'lat': 38.89511, 'lon': -77.03637}}, {'city': 'Hollywood', 'state': 'Florida', 'country': 'United States', 'facility': 'Boehringer Ingelheim Investigational Site', 'geoPoint': {'lat': 26.0112, 'lon': -80.14949}}, {'city': 'Largo', 'state': 'Florida', 'country': 'United States', 'facility': 'Boehringer Ingelheim Investigational Site', 'geoPoint': {'lat': 27.90979, 'lon': -82.78842}}, {'city': 'Ocala', 'state': 'Florida', 'country': 'United States', 'facility': 'Boehringer Ingelheim Investigational Site', 'geoPoint': {'lat': 29.1872, 'lon': -82.14009}}, {'city': 'Pembroke Pines', 'state': 'Florida', 'country': 'United States', 'facility': 'Boehringer Ingelheim Investigational Site', 'geoPoint': {'lat': 26.00315, 'lon': -80.22394}}, {'city': 'Tampa', 'state': 'Florida', 'country': 'United States', 'facility': 'Boehringer Ingelheim Investigational Site', 'geoPoint': {'lat': 27.94752, 'lon': -82.45843}}, {'city': 'Atlanta', 'state': 'Georgia', 'country': 'United States', 'facility': 'Boehringer Ingelheim Investigational Site', 'geoPoint': {'lat': 33.749, 'lon': -84.38798}}, {'city': 'Augusta', 'state': 'Georgia', 'country': 'United States', 'facility': 'Medical College of Georgia', 'geoPoint': {'lat': 33.47097, 'lon': -81.97484}}, {'city': 'Chicago', 'state': 'Illinois', 'country': 'United States', 'facility': 'Rush Presbyterian - St. Lukes Medical Center', 'geoPoint': {'lat': 41.85003, 'lon': -87.65005}}, {'city': 'Des Moines', 'state': 'Iowa', 'country': 'United States', 'facility': 'Boehringer Ingelheim Investigational Site', 'geoPoint': {'lat': 41.60054, 'lon': -93.60911}}, {'city': 'New Orleans', 'state': 'Louisiana', 'country': 'United States', 'facility': 'Louisiana State University Health Science Center', 'geoPoint': {'lat': 29.95465, 'lon': -90.07507}}, {'city': 'Shreveport', 'state': 'Louisiana', 'country': 'United States', 'facility': 'Boehringer Ingelheim Investigational Site', 'geoPoint': {'lat': 32.52515, 'lon': -93.75018}}, {'city': 'Towson', 'state': 'Maryland', 'country': 'United States', 'facility': 'Boehringer Ingelheim Investigational Site', 'geoPoint': {'lat': 39.4015, 'lon': -76.60191}}, {'city': 'Boston', 'state': 'Massachusetts', 'country': 'United States', 'facility': 'Boehringer Ingelheim Investigational Site', 'geoPoint': {'lat': 42.35843, 'lon': -71.05977}}, {'city': 'Springfield', 'state': 'Massachusetts', 'country': 'United States', 'facility': 'Boehringer Ingelheim Investigational Site', 'geoPoint': {'lat': 42.10148, 'lon': -72.58981}}, {'city': 'Eatontown', 'state': 'New Jersey', 'country': 'United States', 'facility': 'Boehringer Ingelheim Investigational Site', 'geoPoint': {'lat': 40.29622, 'lon': -74.05097}}, {'city': 'Newark', 'state': 'New Jersey', 'country': 'United States', 'facility': 'University of Medicine and Dentistry of New Jersey', 'geoPoint': {'lat': 40.73566, 'lon': -74.17237}}, {'city': 'Flushing', 'state': 'New York', 'country': 'United States', 'facility': 'Boehringer Ingelheim Investigational Site', 'geoPoint': {'lat': 40.76538, 'lon': -73.81736}}, {'city': 'Mineola', 'state': 'New York', 'country': 'United States', 'facility': 'Winthrop University Hospital', 'geoPoint': {'lat': 40.74927, 'lon': -73.64068}}, {'city': 'New York', 'state': 'New York', 'country': 'United States', 'facility': 'Harlem Hospital', 'geoPoint': {'lat': 40.71427, 'lon': -74.00597}}, {'city': 'Northport', 'state': 'New York', 'country': 'United States', 'facility': 'Northport VAMC - Medical Service (111)', 'geoPoint': {'lat': 40.90093, 'lon': -73.34317}}, {'city': 'Raleigh', 'state': 'North Carolina', 'country': 'United States', 'facility': 'Wake Nephrology Associates, PA', 'geoPoint': {'lat': 35.7721, 'lon': -78.63861}}, {'city': 'Cleveland', 'state': 'Ohio', 'country': 'United States', 'facility': 'The Cleveland Foundation', 'geoPoint': {'lat': 41.4995, 'lon': -81.69541}}, {'city': 'Philadelphia', 'state': 'Pennsylvania', 'country': 'United States', 'facility': 'Hospital of the University of Pennsylvania', 'geoPoint': {'lat': 39.95238, 'lon': -75.16362}}, {'city': 'Philadelphia', 'state': 'Pennsylvania', 'country': 'United States', 'facility': 'Temple University Hospital', 'geoPoint': {'lat': 39.95238, 'lon': -75.16362}}, {'city': 'Pittsburgh', 'state': 'Pennsylvania', 'country': 'United States', 'facility': 'VA Pittsburgh Healthcare System', 'geoPoint': {'lat': 40.44062, 'lon': -79.99589}}, {'city': 'Charleston', 'state': 'South Carolina', 'country': 'United States', 'facility': 'Medical University of South Carolina', 'geoPoint': {'lat': 32.77632, 'lon': -79.93275}}, {'city': 'Dallas', 'state': 'Texas', 'country': 'United States', 'facility': 'The University of Texas Southwestern Medical Center', 'geoPoint': {'lat': 32.78306, 'lon': -96.80667}}, {'city': 'San Antonio', 'state': 'Texas', 'country': 'United States', 'facility': 'Boehringer Ingelheim Investigational Site', 'geoPoint': {'lat': 29.42412, 'lon': -98.49363}}, {'city': 'San Antonio', 'state': 'Texas', 'country': 'United States', 'facility': 'University of Texas Health and Science Center at San Antonio', 'geoPoint': {'lat': 29.42412, 'lon': -98.49363}}, {'city': 'Burlington', 'state': 'Vermont', 'country': 'United States', 'facility': 'University of Vermont', 'geoPoint': {'lat': 44.47588, 'lon': -73.21207}}, {'city': 'Charlottesville', 'state': 'Virginia', 'country': 'United States', 'facility': 'University of Virginia Health Science Center', 'geoPoint': {'lat': 38.02931, 'lon': -78.47668}}, {'city': 'Gig Harbor', 'state': 'Washington', 'country': 'United States', 'facility': 'Boehringer Ingelheim Investigational Site', 'geoPoint': {'lat': 47.32926, 'lon': -122.58013}}, {'city': 'Seattle', 'state': 'Washington', 'country': 'United States', 'facility': 'Boehringer Ingelheim Investigational Site', 'geoPoint': {'lat': 47.60621, 'lon': -122.33207}}, {'city': 'Milwaukee', 'state': 'Wisconsin', 'country': 'United States', 'facility': 'Clement J. Zablocki Veterans Administration Medical Center', 'geoPoint': {'lat': 43.0389, 'lon': -87.90647}}, {'city': 'Buenos Aires', 'country': 'Argentina', 'facility': 'Boehringer Ingelheim Investigational Site', 'geoPoint': {'lat': -34.61315, 'lon': -58.37723}}, {'city': 'Coronel Suárez', 'country': 'Argentina', 'facility': 'Clinica Coronel Suarez', 'geoPoint': {'lat': -37.45859, 'lon': -61.93294}}, {'city': 'Córdoba', 'country': 'Argentina', 'facility': 'Boehringer Ingelheim Investigational Site', 'geoPoint': {'lat': -31.40648, 'lon': -64.18853}}, {'city': 'Paraná', 'country': 'Argentina', 'facility': 'Boehringer Ingelheim Investigational Site', 'geoPoint': {'lat': -31.73271, 'lon': -60.52897}}, {'city': 'Provincia de Buenos Aires', 'country': 'Argentina', 'facility': 'Boehringer Ingelheim Investigational Site'}, {'city': 'Rosario, Santa Fé', 'country': 'Argentina', 'facility': 'Boehringer Ingelheim Investigational Site', 'geoPoint': {'lat': -32.94682, 'lon': -60.63932}}, {'city': 'Salta', 'country': 'Argentina', 'facility': 'Hospital San Bernardo', 'geoPoint': {'lat': -24.80645, 'lon': -65.41999}}, {'city': 'Santa Fe', 'country': 'Argentina', 'facility': 'Boehringer Ingelheim Investigational Site', 'geoPoint': {'lat': -31.64881, 'lon': -60.70868}}, {'city': 'Kippa-Ring', 'state': 'Queensland', 'country': 'Australia', 'facility': 'Boehringer Ingelheim Investigational Site', 'geoPoint': {'lat': -27.22586, 'lon': 153.0835}}, {'city': 'Elizabeth', 'state': 'South Australia', 'country': 'Australia', 'facility': 'Lyell McEwin Hospital Department of medicine', 'geoPoint': {'lat': -34.72, 'lon': 138.67}}, {'city': 'Geelong', 'state': 'Victoria', 'country': 'Australia', 'facility': 'Geelong Clinical Research Centre', 'geoPoint': {'lat': -38.14711, 'lon': 144.36069}}, {'city': 'Melbourne', 'state': 'Victoria', 'country': 'Australia', 'facility': 'Boehringer Ingelheim Investigational Site', 'geoPoint': {'lat': -37.814, 'lon': 144.96332}}, {'city': 'Belém', 'country': 'Brazil', 'facility': 'Universidade Federal do Pará', 'geoPoint': {'lat': -1.45583, 'lon': -48.50444}}, {'city': 'Botucatu', 'country': 'Brazil', 'facility': 'Boehringer Ingelheim Investigational Site', 'geoPoint': {'lat': -22.88583, 'lon': -48.445}}, {'city': 'Juiz de Fora ¿ MG', 'country': 'Brazil', 'facility': 'Faculdade de Medicina Universidade Federal de Juiz de Fora'}, {'city': 'Vila Clementino, São Paulo', 'country': 'Brazil', 'facility': 'Boehringer Ingelheim Investigational Site'}, {'city': 'Calgary', 'state': 'Alberta', 'country': 'Canada', 'facility': 'Boehringer Ingelheim Investigational Site', 'geoPoint': {'lat': 51.05011, 'lon': -114.08529}}, {'city': 'Red Deer', 'state': 'Alberta', 'country': 'Canada', 'facility': 'Boehringer Ingelheim Investigational Site', 'geoPoint': {'lat': 52.26682, 'lon': -113.802}}, {'city': 'Vancouver', 'state': 'British Columbia', 'country': 'Canada', 'facility': 'BC Endocrine Research Foundation', 'geoPoint': {'lat': 49.24966, 'lon': -123.11934}}, {'city': 'Vancouver', 'state': 'British Columbia', 'country': 'Canada', 'facility': 'Endocrine Research Society', 'geoPoint': {'lat': 49.24966, 'lon': -123.11934}}, {'city': 'Winnipeg', 'state': 'Manitoba', 'country': 'Canada', 'facility': 'University of Manitoba, Diabetes Research Group', 'geoPoint': {'lat': 49.8844, 'lon': -97.14704}}, {'city': 'Halifax', 'state': 'Nova Scotia', 'country': 'Canada', 'facility': 'Division of Respirology', 'geoPoint': {'lat': 44.64269, 'lon': -63.57688}}, {'city': 'Kitchener', 'state': 'Ontario', 'country': 'Canada', 'facility': 'Boehringer Ingelheim Investigational Site', 'geoPoint': {'lat': 43.42537, 'lon': -80.5112}}, {'city': 'London', 'state': 'Ontario', 'country': 'Canada', 'facility': 'Boehringer Ingelheim Investigational Site', 'geoPoint': {'lat': 42.98339, 'lon': -81.23304}}, {'city': 'Mississauga', 'state': 'Ontario', 'country': 'Canada', 'facility': 'Credit Valley Hospital', 'geoPoint': {'lat': 43.5789, 'lon': -79.6583}}, {'city': 'Oakville', 'state': 'Ontario', 'country': 'Canada', 'facility': 'Boehringer Ingelheim Investigational Site', 'geoPoint': {'lat': 43.45011, 'lon': -79.68292}}, {'city': 'Ottawa', 'state': 'Ontario', 'country': 'Canada', 'facility': 'The Ottawa Hospital - Riverside Campus', 'geoPoint': {'lat': 45.41117, 'lon': -75.69812}}, {'city': 'Thornhill', 'state': 'Ontario', 'country': 'Canada', 'facility': 'LIfestyle Metabolism Centre - Thornhill', 'geoPoint': {'lat': 43.80011, 'lon': -79.4163}}, {'city': 'Timmins', 'state': 'Ontario', 'country': 'Canada', 'facility': 'Boehringer Ingelheim Investigational Site', 'geoPoint': {'lat': 48.46686, 'lon': -81.33312}}, {'city': 'Toronto', 'state': 'Ontario', 'country': 'Canada', 'facility': 'Boehringer Ingelheim Investigational Site', 'geoPoint': {'lat': 43.70643, 'lon': -79.39864}}, {'city': 'Toronto', 'state': 'Ontario', 'country': 'Canada', 'facility': "St. Michael's Hospital", 'geoPoint': {'lat': 43.70643, 'lon': -79.39864}}, {'city': 'Toronto', 'state': 'Ontario', 'country': 'Canada', 'facility': "Sunnybrook & Woman's College Health Science Centre", 'geoPoint': {'lat': 43.70643, 'lon': -79.39864}}, {'city': 'Weston', 'state': 'Ontario', 'country': 'Canada', 'facility': 'Humber River Regional Hospital, Dialysis Unit', 'geoPoint': {'lat': 43.70359, 'lon': -79.51513}}, {'city': 'Laval', 'state': 'Quebec', 'country': 'Canada', 'facility': 'Boehringer Ingelheim Investigational Site', 'geoPoint': {'lat': 45.56995, 'lon': -73.692}}, {'city': 'Montreal', 'state': 'Quebec', 'country': 'Canada', 'facility': 'CHUM - Hote-Dieu', 'geoPoint': {'lat': 45.50884, 'lon': -73.58781}}, {'city': 'Montreal', 'state': 'Quebec', 'country': 'Canada', 'facility': 'Hopital Maisonneuve Rosemont', 'geoPoint': {'lat': 45.50884, 'lon': -73.58781}}, {'city': 'Sherbrooke', 'state': 'Quebec', 'country': 'Canada', 'facility': 'CHUS - Hopital Fleurimont', 'geoPoint': {'lat': 45.40008, 'lon': -71.89908}}, {'city': 'Saskatoon', 'state': 'Saskatchewan', 'country': 'Canada', 'facility': 'Boehringer Ingelheim Investigational Site', 'geoPoint': {'lat': 52.13238, 'lon': -106.66892}}, {'city': 'Acapulco Guerrero', 'country': 'Mexico', 'facility': 'Fracc. Magallanes'}, {'city': 'Col. Sección XVI, Deleg. Tlalpan', 'country': 'Mexico', 'facility': 'Boehringer Ingelheim Investigational Site'}, {'city': 'Guadalajara', 'country': 'Mexico', 'facility': 'Cardiology', 'geoPoint': {'lat': 20.67738, 'lon': -103.34749}}, {'city': 'Guadalajara', 'country': 'Mexico', 'facility': 'Hospital Civil Nuevo de Guadalajara', 'geoPoint': {'lat': 20.67738, 'lon': -103.34749}}, {'city': 'Guadalajara, Jalisco', 'country': 'Mexico', 'facility': 'Boehringer Ingelheim Investigational Site'}, {'city': 'Metepec', 'country': 'Mexico', 'facility': 'Dep of Neurology', 'geoPoint': {'lat': 19.25934, 'lon': -99.60175}}, {'city': 'México, D.F.', 'country': 'Mexico', 'facility': 'Cardiologia', 'geoPoint': {'lat': 31.00435, 'lon': -108.15213}}, {'city': 'Auckland', 'country': 'New Zealand', 'facility': 'Boehringer Ingelheim Investigational Site', 'geoPoint': {'lat': -36.84853, 'lon': 174.76349}}, {'city': 'Christchurch', 'country': 'New Zealand', 'facility': '1st Floor Hagely Hostel', 'geoPoint': {'lat': -43.53333, 'lon': 172.63333}}, {'city': 'Daegu', 'country': 'South Korea', 'facility': 'Dongsan Medical Center', 'geoPoint': {'lat': 35.87028, 'lon': 128.59111}}, {'city': 'Gyunggido', 'country': 'South Korea', 'facility': 'National Health Insurance Corporation, Ilsan Hospital'}, {'city': 'Seoul', 'country': 'South Korea', 'facility': 'Yongdong Severance Hospital', 'geoPoint': {'lat': 37.566, 'lon': 126.9784}}, {'city': 'Chiayi City', 'country': 'Taiwan', 'facility': 'Buddhist Tzu Chi General Hospital', 'geoPoint': {'lat': 23.47917, 'lon': 120.44889}}, {'city': 'Hualien City', 'country': 'Taiwan', 'facility': 'Buddhist Tzu Chi General Hospital', 'geoPoint': {'lat': 23.97694, 'lon': 121.60444}}, {'city': 'Tainan', 'country': 'Taiwan', 'facility': 'Chi Mei Medical Center', 'geoPoint': {'lat': 22.99083, 'lon': 120.21333}}, {'city': 'Taipei', 'country': 'Taiwan', 'facility': 'Cathay General Hospital', 'geoPoint': {'lat': 25.05306, 'lon': 121.52639}}, {'city': 'Taipei', 'country': 'Taiwan', 'facility': 'National Taiwan University Hospital', 'geoPoint': {'lat': 25.05306, 'lon': 121.52639}}, {'city': 'Taipei', 'country': 'Taiwan', 'facility': 'Tri-Service General Hospital', 'geoPoint': {'lat': 25.05306, 'lon': 121.52639}}, {'city': 'Bangkok', 'country': 'Thailand', 'facility': 'Bumrungrad Hospital', 'geoPoint': {'lat': 13.75398, 'lon': 100.50144}}, {'city': 'Bangkok', 'country': 'Thailand', 'facility': 'Pramongkutklao Hospital', 'geoPoint': {'lat': 13.75398, 'lon': 100.50144}}, {'city': 'Bangkok', 'country': 'Thailand', 'facility': 'Siriraj Hospital, Division of Hypertension', 'geoPoint': {'lat': 13.75398, 'lon': 100.50144}}, {'city': 'Bangkok', 'country': 'Thailand', 'facility': 'Thummasart University Hospital', 'geoPoint': {'lat': 13.75398, 'lon': 100.50144}}, {'city': 'Chiang Mai', 'country': 'Thailand', 'facility': 'Maharaj Nakom Chiang Mai Hospital', 'geoPoint': {'lat': 18.79038, 'lon': 98.98468}}, {'city': 'Khon Kaen', 'country': 'Thailand', 'facility': 'Srinagarind Hospital', 'geoPoint': {'lat': 16.44671, 'lon': 102.833}}], 'overallOfficials': [{'name': 'Boehringer Ingelheim Study Coordinator', 'role': 'STUDY_CHAIR', 'affiliation': 'Boehringer Ingelheim'}]}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Boehringer Ingelheim', 'class': 'INDUSTRY'}, 'responsibleParty': {'type': 'SPONSOR'}}}}